Cargando…
A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity
PURPOSE: Although doxorubicin chemotherapy is commonly applied for treating different malignant tumors, cardiotoxicity induced by this chemotherapeutic agent restricts its clinical use. The use of silymarin/silibinin may mitigate the doxorubicin-induced cardiac adverse effects. For this aim, the pot...
Autores principales: | Singh, Mandeep, Kadhim, Mustafa M., Turki Jalil, Abduladheem, Oudah, Shamam Kareem, Aminov, Zafar, Alsaikhan, Fahad, Jawhar, Zanko Hassan, Ramírez-Coronel, Andrés Alexis, Farhood, Bagher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173635/ https://www.ncbi.nlm.nih.gov/pubmed/37165384 http://dx.doi.org/10.1186/s12935-023-02936-4 |
Ejemplares similares
-
The key role of microRNA-766 in the cancer development
por: Gupta, Jitendra, et al.
Publicado: (2023) -
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
por: Stilinović, Nebojša, et al.
Publicado: (2012) -
The Protective Effects of Silymarin against Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity in Rats
por: Rašković, Aleksandar, et al.
Publicado: (2011) -
In Vitro Antimicrobial and Modulatory Activity of the Natural Products Silymarin and Silibinin
por: Rakelly de Oliveira, Dayanne, et al.
Publicado: (2015) -
Protective Effects of Silymarin and Silibinin against DNA Damage in Human Blood Cells
por: Fernandes Veloso Borges, Flávio, et al.
Publicado: (2018)